Among outpatients with RA in whom adalimumab was started over 3 years, the development of antidrug antibodies was associated with lower adalimumab concentration and lower likelihood of minimal disease activity or clinical remission.
No takes yet. Share an insight, caveat, or question.
G. M. Bartelds (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: